Bortezomib for patients with advanced-stage bronchioloalveolar carcinoma: A California cancer consortium phase II study (NCI 7003)
- Suresh S. Ramalingam
- , Angela Davies
- , Jeff Longmate
- , Martin Edelman
- , Primo N. Lara
- , Everett E. Vokes
- , Miguel Villalona-Calero
- , Barbara J. Gitlitz
- , Karen Reckamp
- , Ravi Salgia
- , John J. Wright
- , Chandra P. Belani
- , David R. Gandara
- Emory University
- University of California at Davis
- University of Pittsburgh
- VA Medical Center
- City of Hope National Medical Center
- Swedish Medical Center
- (VA) N. California Hlth. Care Syst.
- Department of Medicine
- U.S. Department of Veterans Affairs
- UC Davis Comprehensive Cancer Center
- University of Chicago
- Fox Chase Cancer Center
- University of Maryland Cancer Center
- University of Texas MD Anderson Cancer Center
- Alliance for Clinical Trials in Oncology
- Baptist Hospital Miami
- Ohio State University
- Wake Forest University
- University of Southern California
- City of Hope Comprehensive Cancer Center
- Vanderbilt University
- Cedars-Sinai Medical Center
- Dana-Farber Cancer Institute
- Harvard University
- National Institutes of Health
- Pennsylvania State University
- Drexel University
- University of Arizona
- University of Kansas
Research output: Contribution to journal › Article › peer-review
12
Scopus
citations